Takeda’s zasocitinib bests Sotyktu in phase III psoriasis trial
A preview of the next edition of BioWorld, June 12, 2026
A preview of the next edition of BioWorld, June 12, 2026
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.